Form 4: Akebia Therapeutics CEO John P. Butler Sells Shares to Cover Tax Obligations
SEC Form 4
Akebia Therapeutics CEO John P. Butler sold 46,409 shares of common stock on March 3, 2025, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On March 3, 2025, John P. Butler, CEO and President of Akebia Therapeutics, Inc., sold 46,409 shares of common stock at a price of $1.83 per share.
- The sale was executed automatically by the issuer to cover tax withholding obligations associated with the vesting and settlement of restricted stock units granted on February 28, 2022.
- The transaction was conducted under a Rule 10b5-1 trading plan adopted by Butler on December 1, 2023.
- Following the transaction, Butler directly owns 2,557,921 shares of Akebia Therapeutics common stock.
- Butler also indirectly owns shares through various grantor retained annuity trusts (GRATs) for himself and Dorothy Butler.
Sentiment
Score: 5
Explanation: The document is a routine disclosure of a stock sale by an executive to cover tax obligations. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
Sales of shares by company executives are a normal part of executive compensation. Sales to cover tax obligations are also common. The use of a 10b5-1 plan is a standard practice to avoid insider trading concerns.
Stakeholder Impact
- The sale of shares by the CEO could have a minor negative impact on shareholder sentiment, although it is a common practice for executives to sell shares for tax purposes.
Key Dates
| Date | Description |
|---|---|
| February 28, 2022 | Date of grant for the restricted stock units that triggered the tax withholding obligation. |
| December 1, 2023 | Date John P. Butler adopted the Rule 10b5-1 trading plan. |
| March 3, 2025 | Date of the stock sale transaction. |
| March 4, 2025 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.